DE60133510D1 - Automatisches Verfahren zur quantitativen Bestimmung und Überwachung von exogenem Hämoglobin in Vollblut, Blutplasma und Blutserum - Google Patents

Automatisches Verfahren zur quantitativen Bestimmung und Überwachung von exogenem Hämoglobin in Vollblut, Blutplasma und Blutserum

Info

Publication number
DE60133510D1
DE60133510D1 DE60133510T DE60133510T DE60133510D1 DE 60133510 D1 DE60133510 D1 DE 60133510D1 DE 60133510 T DE60133510 T DE 60133510T DE 60133510 T DE60133510 T DE 60133510T DE 60133510 D1 DE60133510 D1 DE 60133510D1
Authority
DE
Germany
Prior art keywords
blood
hemoglobin
monitoring
plasma
quantitative determination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133510T
Other languages
English (en)
Other versions
DE60133510T2 (de
Inventor
Michael J Malin
Phyllis Shapiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Application granted granted Critical
Publication of DE60133510D1 publication Critical patent/DE60133510D1/de
Publication of DE60133510T2 publication Critical patent/DE60133510T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/726—Devices
DE60133510T 2000-06-09 2001-06-05 Automatisches Verfahren zur quantitativen Bestimmung und Überwachung von exogenem Hämoglobin in Vollblut, Blutplasma und Blutserum Expired - Lifetime DE60133510T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21062500P 2000-06-09 2000-06-09
US210625P 2000-06-09

Publications (2)

Publication Number Publication Date
DE60133510D1 true DE60133510D1 (de) 2008-05-21
DE60133510T2 DE60133510T2 (de) 2009-06-25

Family

ID=22783622

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133510T Expired - Lifetime DE60133510T2 (de) 2000-06-09 2001-06-05 Automatisches Verfahren zur quantitativen Bestimmung und Überwachung von exogenem Hämoglobin in Vollblut, Blutplasma und Blutserum

Country Status (6)

Country Link
US (1) US6623972B2 (de)
EP (1) EP1162461B8 (de)
JP (1) JP4694720B2 (de)
AT (1) ATE391917T1 (de)
DE (1) DE60133510T2 (de)
ES (1) ES2305014T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027347A1 (en) * 2001-05-25 2003-02-06 Phyllis Shapiro Automated method for correcting blood analysis parameter results affected by interference from exogenous blood substitutes in whole blood, plasma, and serum
US8592219B2 (en) * 2005-01-17 2013-11-26 Gyros Patent Ab Protecting agent
EP1849004A1 (de) * 2005-01-17 2007-10-31 Gyros Patent Ab Vielseitiger strömungsweg
US7790464B2 (en) * 2006-05-04 2010-09-07 Blaze Medical Devices, LLC Blood hemolysis analyzer
US8906309B2 (en) * 2009-04-27 2014-12-09 Abbott Laboratories Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer
US8906308B2 (en) 2010-01-15 2014-12-09 Abbott Laboratories Method for determining volume and hemoglobin content of individual red blood cells
US9626650B2 (en) 2011-04-14 2017-04-18 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US10445846B2 (en) 2011-04-14 2019-10-15 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US8599009B2 (en) 2011-08-16 2013-12-03 Elwha Llc Systematic distillation of status data relating to regimen compliance
CN103315710A (zh) * 2013-06-17 2013-09-25 无锡市第三人民医院 光电比色血液丢失计量笔及配套使用的引流瓶
EP2910926A1 (de) * 2014-02-19 2015-08-26 F.Hoffmann-La Roche Ag Verfahren und Vorrichtung zum Zuordnen einer Blutplasmaprobe
KR102235823B1 (ko) 2016-05-11 2021-04-02 노바 바이오메디컬 코포레이션 전혈용 so2 센서
US11504417B2 (en) 2017-07-18 2022-11-22 VirTech Bio, Inc. Blood substitutes comprising hemoglobin and methods of making
GB2573126B (en) * 2018-04-24 2022-11-09 Entia Ltd A method and apparatus for determining haemoglobin concentration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234903A (en) * 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
EP0847768B1 (de) * 1992-10-13 2001-09-19 Baxter International Inc. Hemodialyseüberwachungssystem für Dialyseapparate
US5416026A (en) * 1993-10-04 1995-05-16 I-Stat Corporation Method for detecting the change in an analyte due to hemolysis in a fluid sample
DE69736336T2 (de) 1997-03-03 2007-07-19 NIR Diagnostics Inc., Campbellville Verfahren zur messung von blutersatzstoffen
US6114173A (en) * 1997-04-03 2000-09-05 Bayer Corporation Fully automated method and reagent composition therefor for rapid identification and characterization of reticulocytes erythrocytes and platelets in whole blood
JP3830613B2 (ja) * 1997-04-18 2006-10-04 シスメックス株式会社 血液中の白血球及びヘモグロビン濃度測定試薬
US5858794A (en) * 1997-05-13 1999-01-12 Bayer Corporation Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers

Also Published As

Publication number Publication date
ES2305014T3 (es) 2008-11-01
JP4694720B2 (ja) 2011-06-08
DE60133510T2 (de) 2009-06-25
US6623972B2 (en) 2003-09-23
JP2002040029A (ja) 2002-02-06
EP1162461A3 (de) 2002-03-06
EP1162461B1 (de) 2008-04-09
EP1162461B8 (de) 2008-06-18
EP1162461A2 (de) 2001-12-12
ATE391917T1 (de) 2008-04-15
US20020012904A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
DE60133510D1 (de) Automatisches Verfahren zur quantitativen Bestimmung und Überwachung von exogenem Hämoglobin in Vollblut, Blutplasma und Blutserum
DE60138829D1 (de) Verfahren zur unterscheidung des reizkolons von der entzündlichen darmerkrankung (inflammatory bowel disease, ibd) und zur überwachung von patienten mit ibd unter verwendung von endogenem gesamt-lactoferrin als marker
DE60315373D1 (de) Vorrichtung und Verfahren zur Bestimmung der Konzentration von Analyten
DK0985930T3 (da) Teststrimler til visuel bestemmelse af glucosekoncentrationen i blod
WO2006039310A3 (en) Blood monitoring system
ATE406835T1 (de) Verfahren und vorrichtung zur überwachung der analytkonzentration durch optischen nachweis
DE69801210T2 (de) Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern
WO2007062269A3 (en) Blood monitoring system
DE60011274D1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
ATE546734T1 (de) Risikomarker für eine herzkreislaufkrankheit
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
ATE312550T1 (de) Vorrichtung zur segmentären bioimpedanzmessung von einem dialysepatienten
DE60228684D1 (de) System zur überwachung der konzentration von analyten in körperflüssigkeiten
DE69837709D1 (de) Vorrichtung und verfahren zur bestimmung des analytpegels
DK0883371T3 (da) Metode til overvågning af en patients helbred ved måling og forudsigelse af glukoseniveauet i patientens blodprøve
ATE181599T1 (de) Methode zur bestimmung von hämoglobinaddukten
ATE100150T1 (de) Verfahren zur bestimmung von physiologisch wirksamen substanzen.
WO2002097391A3 (en) Automated method of correcting for interference of mean cell hemoglobin concentration
ATE191976T1 (de) Verfahren zum nachweis von knochen- und anderen bindegewebeerkrankungen in menschen und tieren
ATE262179T1 (de) Verfahren zum nachweis von alpha-oxoaldehyden in vollblut, blutplasma und/oder serum eines patienten
EP1162457A3 (de) Vielfach-Koagulationstestsystem und Verfahren zu seiner Anwendung
RU2426988C1 (ru) Способ прогнозирования течения раннего послеоперационного периода после операции на артерии или артериях, выполненной по поводу облитерирующего атеросклероза артерий нижних конечностей
DE502004012230D1 (de) Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i
ATE148233T1 (de) Verfahren zur bestimmung von thrombose verursachenden lupus-anticoagulant-antikörpern
DE60034334D1 (de) Diagnostisches verfahren für chronische obstruktive lungen krankheit

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS, TARRYTO, US

8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC., TARRYTOWN, US

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC. (N.D.GES.D, US